1. Home
  2. BMEA vs HURC Comparison

BMEA vs HURC Comparison

Compare BMEA & HURC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BMEA
  • HURC
  • Stock Information
  • Founded
  • BMEA 2017
  • HURC 1968
  • Country
  • BMEA United States
  • HURC United States
  • Employees
  • BMEA N/A
  • HURC 716
  • Industry
  • BMEA Biotechnology: Pharmaceutical Preparations
  • HURC Industrial Machinery/Components
  • Sector
  • BMEA Health Care
  • HURC Industrials
  • Exchange
  • BMEA Nasdaq
  • HURC Nasdaq
  • Market Cap
  • BMEA 145.0M
  • HURC 140.8M
  • IPO Year
  • BMEA 2021
  • HURC N/A
  • Fundamental
  • Price
  • BMEA $4.25
  • HURC $21.58
  • Analyst Decision
  • BMEA Buy
  • HURC
  • Analyst Count
  • BMEA 13
  • HURC 0
  • Target Price
  • BMEA $27.92
  • HURC N/A
  • AVG Volume (30 Days)
  • BMEA 831.0K
  • HURC 13.2K
  • Earning Date
  • BMEA 10-29-2024
  • HURC 01-10-2025
  • Dividend Yield
  • BMEA N/A
  • HURC 0.79%
  • EPS Growth
  • BMEA N/A
  • HURC N/A
  • EPS
  • BMEA N/A
  • HURC N/A
  • Revenue
  • BMEA N/A
  • HURC $186,584,000.00
  • Revenue This Year
  • BMEA N/A
  • HURC N/A
  • Revenue Next Year
  • BMEA N/A
  • HURC N/A
  • P/E Ratio
  • BMEA N/A
  • HURC N/A
  • Revenue Growth
  • BMEA N/A
  • HURC N/A
  • 52 Week Low
  • BMEA $3.61
  • HURC $14.83
  • 52 Week High
  • BMEA $20.21
  • HURC $28.20
  • Technical
  • Relative Strength Index (RSI)
  • BMEA 42.32
  • HURC 63.69
  • Support Level
  • BMEA $3.78
  • HURC $17.60
  • Resistance Level
  • BMEA $4.29
  • HURC $18.81
  • Average True Range (ATR)
  • BMEA 0.30
  • HURC 0.96
  • MACD
  • BMEA 0.15
  • HURC 0.25
  • Stochastic Oscillator
  • BMEA 89.71
  • HURC 92.50

About BMEA Biomea Fusion Inc.

Biomea Fusion Inc is a preclinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of irreversible small molecule drugs to treat patients with genetically defined cancers. The company's product candidate, BMF-219, is designed to be an orally bioavailable, potent and selective irreversible inhibitor of menin, an important transcriptional regulator known to play a direct role in oncogenic signaling in multiple cancers.

About HURC Hurco Companies Inc.

Hurco Companies Inc is a United States-based industrial technology company. It designs, manufactures, and sells computerized machine tools, consisting mainly of vertical machining centers and turning centers, to companies in the metal working industry through sales, service and distribution network. The company concentrated on designing user-friendly computer control systems that can be operated by both skilled and unskilled machine tool operators. It generates maximum revenue from the Computerized Machine Tools product. Geographically, It derives a majority of revenue from the United States of America. Its product categories include 5-Axis VMC; 3-Axis VMC; Horizontal MC and Turning Centers.

Share on Social Networks: